11/13/2024
3:14 PM | Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:17 PM | Agios Pharmaceuticals (Subject)
Ballal Rahul D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
1:40 PM | Agios Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
10/31/2024
8:20 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
5:56 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
3:15 PM | Agios Pharmaceuticals (Issuer)
Jones Cecilia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:12 PM | Agios Pharmaceuticals (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/13/2024
3:15 PM | Agios Pharmaceuticals (Issuer)
Ballal Rahul D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:15 PM | Agios Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
8:49 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
6:03 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
3:30 PM | Agios Pharmaceuticals (Issuer)
Gheuens Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
4:06 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
4:29 PM | Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:31 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:32 PM | Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:13 PM | Agios Pharmaceuticals (Issuer)
CAPELLO JEFFREY D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:15 PM | Agios Pharmaceuticals (Issuer)
Owen Catherine E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:18 PM | Agios Pharmaceuticals (Issuer)
Scadden David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:19 PM | Agios Pharmaceuticals (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:20 PM | Agios Pharmaceuticals (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:22 PM | Agios Pharmaceuticals (Issuer)
Ballal Rahul D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
6:50 PM | Agios Pharmaceuticals (Subject)
Goff Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
3:14 PM | Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
6:09 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
8:20 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
6:01 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:03 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:47 PM | Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:49 PM | Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:26 PM | Agios Pharmaceuticals (Subject)
Foster-Cheek Kaye I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
5:05 PM | Agios Pharmaceuticals (Subject)
Foster-Cheek Kaye I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:06 PM | Agios Pharmaceuticals (Subject)
Foster-Cheek Kaye I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
8:21 PM | Agios Pharmaceuticals (Subject)
Schenkein David P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
4:43 PM | Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
9:33 AM | Agios Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
6:03 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
4:50 PM | Agios Pharmaceuticals (Issuer)
Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
1:21 PM | Agios Pharmaceuticals (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
5:07 AM | Agios Pharmaceuticals (Subject)
BB BIOTECH AG (Filed by)
| Form SC 13G/A | |
02/12/2024
10:21 AM | Agios Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
Do this Before Elon’s Reveal on January 22nd (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
02/12/2024
9:50 AM | Agios Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/08/2024
10:39 AM | Agios Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
01/24/2024
3:20 PM | Agios Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:22 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:23 PM | Agios Pharmaceuticals (Issuer)
Jones Cecilia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:24 PM | Agios Pharmaceuticals (Issuer)
Gheuens Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:25 PM | Agios Pharmaceuticals (Issuer)
Burns James William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
11:37 AM | Agios Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/09/2024
3:25 PM | Agios Pharmaceuticals (Issuer)
Burns James William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:26 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:28 PM | Agios Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:22 PM | Agios Pharmaceuticals (Issuer)
Gheuens Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:58 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:10 PM | Agios Pharmaceuticals (Issuer)
Milanova Tsveta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
